leisure time -WSS

leisure time

author：explore 2025-10-02 18:47:39 - browse：23141

Cathy McMorris Rodgers -- health policy coverage from STAT — Rep. Cathy McMorris Rodgers announced her plans to leave Congress at the end of 2024. Anna Moneymaker/Getty Images

WASHINGTON — Rep. Cathy McMorris Rodgers, the chair of a crucial House committee that handles health care issues, plans to leave Congress at the end of the year, she announced Thursday.

It will be a major shakeup for a panel already ravaged by Republican retirements. Reps. Michael Burgess (R-Texas), Larry Bucshon (R-Ind.), Jeff Duncan (R-S.C.), Debbie Lesko (R-Ariz.), Greg Pence (R-Ind.) and Kelly Armstrong (R-N.D.) are all leaving at the end of this Congress, too.

Under McMorris Rodgers, the panel led the way for House passage of a health care price transparency package that included the first major proposal to equalize payment between hospital outpatient departments and physician offices.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Food as medicine: Medically tailored meals may get standardized

hotspot

WSS

Roche subsidiary Foundation Medicine opens new headquarters

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Researchers separate signal from noise in heart wearable data

Readout Newsletter: Merck, Vertex, and Viking updates

Why some people catch Covid but never get sick

Donor acceptance rates hint at racial, gender bias in heart transplants: study

entertainment

leisure time

hotspot

In Memoriam: Notable people who died in 2023

'Reaching a detente': STAT's Helen Branswell on covering Covid

Malaria cases in Florida and Texas: Here’s what you need to know

Scientists boost immune system in aging mice by making it youthful

United colonoscopy coverage change 'may cost lives,' doctors say

TikTok cracks down on users posting about weight loss drugs

Psychedelics group wrestles with new pharma identity

Stanford updates investigation of president’s past research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The kidney, in all its complexity, is captured in a new atlas

leisure time

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Why the Crimean Bridge is key to Russia's war in Ukraine

Washington mulls new rules to avert another Change Healthcare

Man who had jail sentence commuted by Trump arrested again

Readout Newsletter: Merck, Vertex, and Viking updates

leisure time

hotspot

Wikipedia

focus